Please provide your email address to receive an email when new articles are posted on . A 42-year-old man presented to the emergency department with complaints of difficulty ambulating, fatigue, ...

Findings showed the study did not meet its primary endpoint of preventing CMV infection in seronegative participants. Topline results were announced from a phase 3 study evaluating Moderna’s ...

CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company's ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

In this case, one arm of the antibody binds to an infected cell carrying cytomegalovirus proteins. The other arm attaches directly to a T cell. The antibody acts as a physical bridge, pulling the T ...

Aim To conduct an analysis of ophthalmic manifestations in leukaemic patients and evaluate their impact on visual outcomes and disease remission. Methods This retrospective, comparative study included ...

For women with a rare form of blindness, their hormones may make the disease worse, new research from UT Southwestern Medical Center suggests. In a study published in the journal Science Advances, ...

According to Aldeyra Therapeutics, a phase 2/3 trial of ADX-2191 in patients with retinitis pigmentosa is expected to begin in 2025. The Food and Drug Administration (FDA) has granted Fast Track ...

Cytomegalovirus (CMV) recently caused a 2-month-old girl in Pennsylvania to suffer severe hearing loss after it was passed to her in the womb. While the virus can exist in a person for life without ...

New research from the University of Pittsburgh School of Medicine and La Jolla Institute for Immunology, published today in Nature Microbiology, reveals an opportunity for developing a therapy against ...